Moon Sung-Ung, Kim Hyung-Hwan, Kim Tong-Soo, Choi Kyung-Mi, Oh Chang-Mi, Ahn Yong-Joo, Hwang Seo-Kyoung, Sohn Youngjoo, Shin E-Hyun, Kim Hyuck, Lee Hyeong-Woo
Department of Pathology, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610, USA.
Clin Vaccine Immunol. 2010 Aug;17(8):1183-7. doi: 10.1128/CVI.00101-10. Epub 2010 Jun 16.
To develop a vaccine to block the transmission of vivax malaria, the gene encoding the ookinete surface protein Pvs25 was cloned from a Korean malaria patient. The Pvs25 gene was 660 bp long, encoding 219 amino acids. It was subcloned into the expression vector pQE30 and expressed in Escherichia coli. The expressed recombinant protein, named rPvs25, showed a molecular mass of approximately 25 kDa by SDS-PAGE analysis. An anti-rPvs25 monoclonal antibody produced in BALB/c mice was able to inhibit sporozoite development in the mosquito Anopheles sinensis, which is known as the malaria transmission vector in the Republic of Korea. In addition, rPvs25 produced a relatively high antibody titer in BALB/c mice that lasted for more than 6 months. Based on these results, we suggest that recombinant Pvs25 could be a useful antigen in the development of a vaccine to prevent local malaria transmission in the Republic of Korea.
为研发一种阻断间日疟传播的疫苗,从一名韩国疟疾患者身上克隆了编码动合子表面蛋白Pvs25的基因。Pvs25基因长度为660 bp,编码219个氨基酸。将其亚克隆到表达载体pQE30中并在大肠杆菌中表达。通过SDS-PAGE分析,表达的重组蛋白rPvs25显示分子量约为25 kDa。在BALB/c小鼠中产生的抗rPvs25单克隆抗体能够抑制中华按蚊(韩国已知的疟疾传播媒介)中疟原虫的发育。此外,rPvs25在BALB/c小鼠中产生了相对较高的抗体滴度,且持续超过6个月。基于这些结果,我们认为重组Pvs25可能是研发预防韩国当地疟疾传播疫苗的一种有用抗原。